Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
BRP [BRINP2-related Peptide]
As low as
70
CHF
CHF 70.00
In stock
Only %1 left
AG-CP3-0048-M0055 mgCHF 70.00
AG-CP3-0048-M02525 mgCHF 210.00
NEW
BULK available!
Research Use Only (RUO). NOT ALLOWED FOR USE IN HUMANS.

Product Details | |
---|---|
Synonyms | H-THRILRRLFNLC-NH2 |
Product Type | Chemical |
Properties | |
Formula |
C68H117N25O14S |
MW | 1540.9 |
Sequence |
H-Thr-His-Arg-Ile-Leu-Arg-Arg-Leu-Phe-Asn-Leu-Cys-NH2 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥95% (HPLC) |
Appearance | White lyophilized powder. |
Solubility | Soluble in water (1mg/ml). |
InChi Key | HMJIRJDBVYKLDC-KVBBLKIJSA-N |
Smiles | CC[C@@H]([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CS)=O)CC(C)C)=O)CC(N)=O)=O)CC1=CC=CC=C1)=O)CC(C)C)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC(C)C)=O)NC([C@@H](NC([C@@H](NC([C@H]([C@H](O)C)N)=O)CC2=CNC=N2)=O)CCCNC(N)=N)=O)C |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Keep cool and dry. |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
- BRP (BRINP2-related peptide) is a 12-amino acid peptide, which was discovered through Peptide Predictor, a computational-functional approach based on prohormone convertase (PCSK) prohormone processing. BRP is generated by the cleavage of the 78-kDa secreted parent protein BRINP2 by enzymes such as PCSK1. The C-terminal amidation of BRP is critical for bioactivity. In mice, humans and pigs, BRINP2 is predominantly expressed in the brain.
- When administered pharmacologically, BRP reduces food intake and exhibits anti-obesity effects in mice and pigs. BRP administration triggers central FOS activation and acts independently of leptin, GLP-1 receptor (GLP1R) and melanocortin 4 receptor (MC4R). Instead, it activates the central CREB-FOS signaling pathway, specifically by activating some regions of the hypothalamus. BRP does not cause changes in pancreatic activity and does not affect blood glucose levels and insulin secretion. It also does not induce nausea or aversion, unlike GDF15, showing certain advantages in improving metabolism.
Product References
- Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide: L. Coassolo, et al.; Nature (Epub ahead of print) (2025)